{ "description": "These codes are currently 'TBD' codes. The CG WG plans to request formal LOINC codes to replace these codes as these concepts are validated.", "_filename": "CodeSystem-tbd-codes-cs.json", "package_name": "hl7.fhir.uv.genomics-reporting", "date": "2023-12-18T22:45:59+00:00", "publisher": "HL7 International / Clinical Genomics", "jurisdiction": [ { "coding": [ { "code": "001", "system": "http://unstats.un.org/unsd/methods/m49/m49.htm", "display": "World" } ] } ], "content": "complete", "name": "TbdCodesCS", "type": null, "experimental": "false", "resourceType": "CodeSystem", "title": "To Be Determined Codes", "package_version": "3.0.0-ballot", "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg", "valueCode": "cg" } ], "status": "active", "id": "daaa95fa-15e4-499b-a548-f03b878d8002", "kind": null, "count": 13, "url": "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs", "concept": [ { "code": "associated-therapy", "display": "Associated Therapy", "definition": "The non-medication therapy (procedure) associated with this implication." }, { "code": "molecular-consequence", "display": "Molecular Consequence", "definition": "The calculated or observed effect of a DNA variant on its downstream transcript and, if applicable, ensuing protein sequence." }, { "code": "feature-consequence", "display": "Feature Consequence", "definition": "The structural implications of a variant (e.g. the variant disrupts a regulatory region, the variant is an inframe insertion)." }, { "code": "diagnostic-implication", "display": "Diagnostic Implication", "definition": "An observation linking a genomic finding with a knowledge base, providing context that may aid in diagnosing a patient with a particular phenotype or condition." }, { "code": "therapeutic-implication", "display": "Therapeutic Implication", "definition": "An observation linking a genomic finding with a knowledge base, providing potential evidence of an interaction with a specified medication or non-medicinal therapy. Ramifications may include alterations in drug metabolism (or pharmacokinetics) that determine the concentration of the drug, prodrug, and/or break-down products over time; alterations in drug efficacy (or pharmacodynamics) that determine how effective a drug is at a given concentration; alterations that alter the risk of adverse drug events, or other types of implications that indicate altered responsiveness to other types of therapies." }, { "code": "functional-effect", "display": "Functional Effect", "definition": "The effect of a variant on downstream biological products or pathways (from Sequence Ontology)." }, { "code": "conclusion-string", "display": "Conclusion Text", "definition": "Clinical conclusion (interpretation) of the observation." }, { "code": "condition-inheritance", "display": "Condition Inheritance", "definition": "The transmission pattern of the condition/phenotype in a pedigree." }, { "code": "variant-confidence-status", "display": "Variant Confidence Status", "definition": "The confidence of a true positive variant call." }, { "code": "repeat-motif", "display": "Repeat Expansion Motif", "definition": "Nucleotides of a repeat expansion motif." }, { "code": "repeat-number", "display": "Number of Repeat Expansions", "definition": "Number of repeats of a repeat expansion." }, { "code": "biomarker-category", "display": "A characterization of a given biomarker observation." }, { "code": "protein-ref-seq", "display": "An identifier for the protein reference sequence." } ], "caseSensitive": true, "version": "3.0.0-ballot", "contact": [ { "name": "HL7 International / Clinical Genomics", "telecom": [ { "value": "http://www.hl7.org/Special/committees/clingenomics", "system": "url" }, { "value": "cg@lists.HL7.org", "system": "email" } ] } ] }